Form 4: GoodRx Holdings Executive Wendy Lynn Barnes Reports Acquisition of Stock Options and Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Wendy Lynn Barnes, a Director and Officer (Chief Executive Officer and President) of GoodRx Holdings, Inc., reported the acquisition of stock options and restricted stock units.

Summary

  • On March 3, 2025, Wendy Lynn Barnes acquired 2,828,232 stock options with an exercise price of $4.85, vesting over 15 quarters starting January 15, 2026.
  • Barnes also acquired 1,842,374 restricted stock units (RSUs) vesting over 13 quarters starting January 15, 2026, and 409,416 RSUs vesting over 6 quarters starting January 15, 2026.
  • The reported transactions did not involve any sale of securities.
  • Following these transactions, Barnes directly owns 2,828,232 stock options, 1,842,374 RSUs, and 409,416 RSUs.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard regulatory filing. The acquisition of stock options and RSUs by an executive can be seen as a slightly positive sign, indicating confidence in the company, but it's not a strong indicator.

Positives

  • The acquisition of stock options and restricted stock units by a key executive could be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting schedules of the stock options and RSUs suggest a multi-year commitment from the executive.

Industry Context

This filing is a routine disclosure related to executive compensation and is common in publicly traded companies. It provides transparency into the alignment of management's interests with those of shareholders.

Comparison to Industry Standards

  • Stock option and RSU grants are standard components of executive compensation packages in the technology and healthcare industries.
  • Vesting schedules are typical, designed to incentivize long-term performance and retention.
  • The specific amounts and vesting terms would need to be compared against peer companies to assess competitiveness.

Stakeholder Impact

  • The transactions could have a minor positive impact on shareholder sentiment if viewed as a sign of executive confidence.
  • Employees may view the grants as a positive sign of the company's commitment to its leadership.

Key Dates

DateDescription
03/03/2025Date of transaction (acquisition of stock options and restricted stock units)
03/05/2025Date of Form 4 filing
01/15/2026Vesting start date for stock options and restricted stock units
03/03/2035Expiration date for stock options

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.